Esperion Therapeutics | ESPR - Ebitda





Ebitda Zmiana Data
AbbVie USD 5.37B 1.85B 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cipla INR 9.55B 3B 2026-03
CSL USD 3.13B 1.17B 2025-12
Cytokinetics USD -169.32M 19.48M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 12.14B 4.26B 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Geron USD -21.29M 11.82M 2025-12
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Merck USD 6.3B 2.09B 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Sanofi EUR 3.31B 3.65B 2026-03
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12